Drugs / symponi
last change Nov 2018 re-read 3 minutes ago

symponi

Developed for
rheumatoid arthritis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT02353780 Comparator Mar 2015 → Dec 2017 rheumatoid arthritis Dr. Larry W. Moreland Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as symponi ClinicalTrials.gov intervention name — accepted as the source's own label NCT02353780 ↗